DOP2008000053A - Inhibidores de akt(proteinas cinasa b) - Google Patents

Inhibidores de akt(proteinas cinasa b)

Info

Publication number
DOP2008000053A
DOP2008000053A DO2008000053A DO2008000053A DOP2008000053A DO P2008000053 A DOP2008000053 A DO P2008000053A DO 2008000053 A DO2008000053 A DO 2008000053A DO 2008000053 A DO2008000053 A DO 2008000053A DO P2008000053 A DOP2008000053 A DO P2008000053A
Authority
DO
Dominican Republic
Prior art keywords
cinasa
proteinas
akt inhibitors
compounds
salt
Prior art date
Application number
DO2008000053A
Other languages
English (en)
Inventor
Michael Ray Myers
Renhua Li
Sajan Joseph
Aktham Aburub
Jenny Pinggi Dai
Christopher Randall Schmid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DOP2008000053A publication Critical patent/DOP2008000053A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a 4-[5-(2-amino-etanosulfonil)-isoquinolin-7-il]-fenol o una sal farmacéuticamente aceptable o un hidrato del compuesto o la sal del mismo, como inhibidores de AKt, que son agentes antineoplásicos y/o antivirales, así como también a composiciones que comprende estos compuestos y a métodos para usar estos compuestos.
DO2008000053A 2006-06-20 2008-10-24 Inhibidores de akt(proteinas cinasa b) DOP2008000053A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19

Publications (1)

Publication Number Publication Date
DOP2008000053A true DOP2008000053A (es) 2009-01-15

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2008000053A DOP2008000053A (es) 2006-06-20 2008-10-24 Inhibidores de akt(proteinas cinasa b)

Country Status (28)

Country Link
US (1) US7998977B2 (es)
EP (1) EP2035385B1 (es)
JP (1) JP2009541335A (es)
KR (1) KR101067551B1 (es)
AR (1) AR061240A1 (es)
AT (1) ATE455102T1 (es)
AU (1) AU2007261120A1 (es)
BR (1) BRPI0713136A2 (es)
CA (1) CA2652612A1 (es)
CL (1) CL2007001752A1 (es)
DE (1) DE602007004333D1 (es)
DK (1) DK2035385T3 (es)
DO (1) DOP2008000053A (es)
EA (1) EA015712B1 (es)
EC (1) ECSP088992A (es)
ES (1) ES2336630T3 (es)
HR (1) HRP20100147T1 (es)
IL (1) IL195005A0 (es)
MA (1) MA30757B1 (es)
MX (1) MX2008015904A (es)
NO (1) NO20090289L (es)
PE (1) PE20080338A1 (es)
PL (1) PL2035385T3 (es)
PT (1) PT2035385E (es)
SI (1) SI2035385T1 (es)
TN (1) TNSN08529A1 (es)
TW (1) TW200812970A (es)
WO (1) WO2007149730A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (en) 2010-09-07 2013-10-23 Dmi Acquisition Corp TREATMENT OF DISEASES
WO2013055749A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
SG10201605205VA (en) 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20160104612A (ko) 2013-07-26 2016-09-05 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조성물
RU2020136589A (ru) 2014-08-18 2020-12-24 Ампио Фармасьютикалз, Инк. Лечение дегенеративных заболеваний суставов
US10123997B2 (en) * 2015-06-15 2018-11-13 Yong Liao Target for treating hepatitis B virus
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
CN115843298B (zh) * 2020-07-22 2024-03-29 南京正大天晴制药有限公司 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐及晶型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136458A0 (en) 2000-05-30 2001-06-14 Peptor Ltd Protein kinase inhibitors
JP2006521382A (ja) 2003-03-28 2006-09-21 イーライ リリー アンド カンパニー Ａｋｔ（プロテインキナーゼｂ）阻害剤
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
WO2005054202A1 (en) * 2003-11-25 2005-06-16 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)

Also Published As

Publication number Publication date
BRPI0713136A2 (pt) 2012-04-17
WO2007149730A2 (en) 2007-12-27
EP2035385B1 (en) 2010-01-13
CL2007001752A1 (es) 2008-01-18
KR101067551B1 (ko) 2011-09-27
DE602007004333D1 (de) 2010-03-04
US7998977B2 (en) 2011-08-16
US20090221633A1 (en) 2009-09-03
AU2007261120A1 (en) 2007-12-27
EP2035385A2 (en) 2009-03-18
ES2336630T3 (es) 2010-04-14
SI2035385T1 (sl) 2010-05-31
JP2009541335A (ja) 2009-11-26
EA015712B1 (ru) 2011-10-31
CA2652612A1 (en) 2007-12-27
PE20080338A1 (es) 2008-04-25
ATE455102T1 (de) 2010-01-15
TW200812970A (en) 2008-03-16
KR20090015978A (ko) 2009-02-12
PT2035385E (pt) 2010-03-01
NO20090289L (no) 2009-01-19
WO2007149730A3 (en) 2008-04-24
PL2035385T3 (pl) 2010-06-30
EA200970041A1 (ru) 2009-06-30
DK2035385T3 (da) 2010-03-22
HRP20100147T1 (hr) 2010-04-30
MX2008015904A (es) 2009-01-12
IL195005A0 (en) 2009-08-03
AR061240A1 (es) 2008-08-13
MA30757B1 (fr) 2009-10-01
ECSP088992A (es) 2009-01-30
TNSN08529A1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
DOP2008000053A (es) Inhibidores de akt(proteinas cinasa b)
CR20110339A (es) Compuestos útiles para inhibir chk1
EA200970856A1 (ru) Ингибиторы пути хеджхога
CL2011000504A1 (es) Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer.
PA8828201A1 (es) Compuestos triazina como inhibidores mtor y quinasa p13
UY32730A (es) Inhibidores de cyp17
ATE479687T1 (de) Kinaseinhibitoren
ECSP055867A (es) Derivados de pirrolopirimidina
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
CR20140036A (es) Compuesto inhibidor de la señalización de la trayectoria notch
DOP2011000113A (es) Pirazolilaminopiridinas como inhibidores de fak
CL2009000914A1 (es) Compuestos derivados de 1-ciano-3-pirrolidinil-n-sustituidas-sulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica.
TN2010000038A1 (en) Organic compounds
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
CO6440548A2 (es) 1-/arilsulfonil)-4-(piperazin-1-il)-1h-benzimidazoles como ligandos de 5-hidroxitriptamina-6.
CR10199A (es) Derivados de benzimidazol
NI201100035A (es) Agentes antifúngicos.
AR057403A1 (es) 4- anilino-3-quinolincarbonitrilos para el tratamiento del cancer
MX2009003793A (es) Inhibidores de cinasa.
GT200600132A (es) Una oxindoloxazolidinona como agente antibacteriano
CL2009000386A1 (es) Compuestos derivados de oxazolidinona; composición farmacéutica que contiene dichos compuestos; y su uso para prevenir o tratar una infección bacteriana.